1. Home
  2. IMA vs THTX Comparison

IMA vs THTX Comparison

Compare IMA & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMA
  • THTX
  • Stock Information
  • Founded
  • IMA 2019
  • THTX 1993
  • Country
  • IMA United States
  • THTX Canada
  • Employees
  • IMA N/A
  • THTX N/A
  • Industry
  • IMA Biotechnology: Biological Products (No Diagnostic Substances)
  • THTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMA Health Care
  • THTX Health Care
  • Exchange
  • IMA Nasdaq
  • THTX Nasdaq
  • Market Cap
  • IMA 159.1M
  • THTX 144.8M
  • IPO Year
  • IMA N/A
  • THTX N/A
  • Fundamental
  • Price
  • IMA $9.14
  • THTX $3.30
  • Analyst Decision
  • IMA
  • THTX Hold
  • Analyst Count
  • IMA 0
  • THTX 1
  • Target Price
  • IMA N/A
  • THTX N/A
  • AVG Volume (30 Days)
  • IMA 41.0K
  • THTX 345.2K
  • Earning Date
  • IMA 01-01-0001
  • THTX 10-09-2025
  • Dividend Yield
  • IMA N/A
  • THTX N/A
  • EPS Growth
  • IMA N/A
  • THTX N/A
  • EPS
  • IMA N/A
  • THTX N/A
  • Revenue
  • IMA $4,300,000.00
  • THTX $84,378,000.00
  • Revenue This Year
  • IMA N/A
  • THTX N/A
  • Revenue Next Year
  • IMA N/A
  • THTX $13.76
  • P/E Ratio
  • IMA N/A
  • THTX N/A
  • Revenue Growth
  • IMA N/A
  • THTX 2.19
  • 52 Week Low
  • IMA $7.95
  • THTX $1.12
  • 52 Week High
  • IMA $23.28
  • THTX $3.31
  • Technical
  • Relative Strength Index (RSI)
  • IMA N/A
  • THTX 75.09
  • Support Level
  • IMA N/A
  • THTX $3.18
  • Resistance Level
  • IMA N/A
  • THTX $3.27
  • Average True Range (ATR)
  • IMA 0.00
  • THTX 0.02
  • MACD
  • IMA 0.00
  • THTX -0.00
  • Stochastic Oscillator
  • IMA 0.00
  • THTX 85.71

About IMA ImageneBio Inc. Common Stock

ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.

About THTX Theratechnologies Inc.

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

Share on Social Networks: